Donna Berry on Symptom Distress and Adherence

Article

Donna L. Berry, from Dana-Farber Cancer Institute, on Symptom Distress and Oral Therapy Adherence.

Donna L. Berry, PhD, RN, AOCN, FAAN, Dana-Farber Cancer Institute, Director, The Phyllis F. Cantor Center for Nursing Research, Associate Professor of Medicine, Harvard Medical School, discusses a study that examined the relationship between symptom distress and adherence to oral chemotherapy or hormonal therapy that is taken at home.

The study enrolled 77 patients with a range of cancer diagnoses and found that as symptom distress increased, adherence decreased. Inversely, those reporting low symptom distress reported perfect adherence to therapy.

Berry notes that the findings from the study stress the importance of proper patient education and appropriate symptom management. Teaching a patient how to deal with the side effects of oral therapy may help improve adherence.

Recent Videos
Meaghan Mooney, B.S.N., RN, OCN, during the Extraordinary Healer interview
Colleen O’Leary, DNP, RN, AOCNS, EBP-C, LSSYB, in an interview with Oncology Nursing News.
Michelle H. Johann, DNP, RN, PHN, CPAN, WTA, in an interview with Oncology Nursing News explaining surgical path cards
Alison Tray, of Hartford Healthcare, discusses her team's research on a multidisciplinary team approach to manage the cancer drug shortage
Related Content
© 2024 MJH Life Sciences

All rights reserved.